BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes
Clinical trial NCT03613402 · WITHDRAWN
Trial details
- NCT number
- NCT03613402
- Sponsor
- Portola Pharmaceuticals
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-01
- Primary completion
- 2020-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.